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China’s methadone maintenance treatment program was initiated in
2004 as a small pilot project in just eight sites. It has since expanded
intoanationwideprogramencompassingmore than680 clinicscover-
ing 27 provinces and serving some 242000 heroin users by the end of
2009. The agencies that were tasked with the program’s expansion
have been confronted with many challenges, including high drop-out
rates, poor cooperation between local governing authorities and poor
service quality at the counter. In spite of these difficulties, ongoing
evaluation has suggested reductions in heroin use, risky injection
practices and, importantly, criminal behaviours among clients,
which has thus provided the impetus for further expansion. Clinic
services have been extended to offer clients a range of ancillary ser-
vices, including HIV, syphilis and hepatitis C testing, information,
education and communication, psychosocial support services and re-
ferrals for treatment of HIV, tuberculosis and sexually transmitted
diseases. Cooperation between health and public security officials
has improved through regular meetings and dialogue. However, insti-
tutional capacity building is still needed to deliver sustainable and
standardized services that will ultimately improve retention rates.
This article documents the steps China made in overcoming the
many barriers to success of its methadone program. These lessons
might be useful for other countries in the region that are scaling-up
their methadone programs.
Keywords Methadone maintenance treatment, scaling-up, national program,
challenges, China
Introduction
Under the leadership of Chairman Mao, China experi-
enced a relatively drug-free period between the 1950s
and the 1970s.
1–5 However, in the late 1970s, the coun-
try underwent economic reforms and the illicit drug
trade re-emerged, first within the border areas adjacent
to the ‘Golden triangle’, then along drug trafficking
routes to other parts of the country.
2,6,7 In 1989, the
first HIV outbreak was identified among 146 injecting
drug users in Yunnan province.
8 Since then, China has
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ii29observed an ever-growing HIV/AIDS epidemic, initially
fuelled by injecting drug users.
9 In 2001, up to 66.5% of
newly diagnosed HIV infections were related to drug
use.
10 Harm reduction efforts began in 2003 and have
slowed the pace of HIV infection among drug users;
11
HIV prevalence has stabilized and reduced, particularly
since 2005 (Figure 1), with the overall growth rate of
newly reported cases having decreased from 9.0% in
2006 to 5.8% in 2009.
12 However, drug users still repre-
sent a major driver of the HIV epidemic in China.
In the early 1990s, government officials began the
lengthy process of understanding how best to con-
strain the dual epidemic of HIV and drug use.
13
This included learning from other countries, develop-
ing policies and plans suitable to China, piloting harm
reduction strategies and ultimately implementing a
multifaceted program to slow the HIV epidemic
among drug users. A major component of this pro-
gram has been the methadone maintenance treatment
(MMT) program, which was initiated in 2004. The
program was rapidly expanded from the initial pilot
of just 8 clinics serving 1029 drug users in 2004 to 680
clinics serving 112831 drug users daily in 2009. This
article provides a detailed roadmap of this process,
and discusses emerging issues and responses that
contributed to the development of the world’s largest
MMT program
14 and the challenges still faced in the
expansion of its services (summarized in Figure 2).
The Pilot Phase
Development of a supportive policy
environment
When first introduced, harm reduction was controver-
sial because it conflicted with laws and regulations on
narcotics control. Thus, despite a large body of
evidence supporting the effectiveness of MMT,
15–17 it
was initially difficult to convince government officials,
especially those in law enforcement, to try this strat-
egy. In order to do so, public health professionals
from the National Center of AIDS/STD Control and
Prevention (NCAIDS) took the bold step to explore
the feasibility and effectiveness of MMT by conduct-
ing pilot interventions, predicting the trend of the
epidemic and advocating for evidence-based policy.
As early as the mid-1990s, Chinese officials began to
organize study tours to learn from the experiences of
other nations, such as Australia, the USA, the UK and
The Netherlands.
13 Delegations typically consisted of
officials from the Ministries of Health, Public
Security, Justice, Education and Finance. These
tours influenced the attitudes of key officials towards
harm reduction, making them more amenable to the
idea of tailoring such strategies to the Chinese con-
text. Further reinforcement came in the form of fre-
quent workshops, conferences and seminars among
key sectors as well as with international agencies,
such as the WHO, United Nations (UN) and World
Bank, and academic institutions, both local and inter-
national. These meetings opened dialogue on the
issues and built a foundation for future collaboration
between sectors, which ultimately led to a consensus
to trial MMT in China.
In the meantime, the underlying policy environment
was changing. Prior to 2001, efforts focused on policy
advocacy and development. The Medium- and
Long-Term Strategic Plan for HIV/AIDS (1998–2010)
18
issued in 1998 was China’s first HIV-specific policy
document with clear targets. It resolved to contain
the rapid spread of HIV among injecting drug users
by 2002 and mandated HIV/STD education in drug
rehabilitation centres and prisons, as well as in
schools. This plan was superseded by the National
Action Plan on HIV/AIDS Prevention and Containment
(2001–2005) issued in 2001,
19 in which it was recog-
nized that the HIV epidemic among injecting drug
users had still not been brought under control.
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Figure 1 HIV sentinel surveillance data for drug users, 1995–2009
ii30 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYThus, higher targets for educational interventions
were set and harm reduction as a control strategy
was formally introduced. The Plan called for a pilot
of pharmacotherapy to treat drug users in therapeutic
institutions, with the guidelines to be developed and
approved by the Ministries of Health and Public
Security.
The National Working Group and pilot
protocol
A National Working Group for Community-based
Maintenance Treatment for Opiate Users (hereafter
referred to as the National Working Group) was es-
tablished in August 2002, consisting of members of
the Ministries of Health, Public Security, and the
State Food and Drug Administration, and three ex-
perts on addiction and HIV/AIDS. The National
Working Group was given overall responsibility for
managing the program, supervising the operation
and overseeing its expansion. At the provincial and
county level, working groups have also been estab-
lished to take on these duties locally. The NCAIDS
serves as the secretariat for the National Working
Group, which is tasked with executing the national
plan, coordinating the implementation, providing
technical support to the clinics and conducting rou-
tine monitoring and evaluation. The National
Working Group members meet regularly to identify
potential gaps, resolve emerging issues and refine
the management of the program. The first task was
to develop guidelines for the MMT pilot. Prior to de-
velopment of the guidelines, the Secretariat arranged
visits to MMT clinics in Hong Kong, the USA, the UK
and The Netherlands in order to develop a plan based
on international best practices. The national guide-
lines were drafted by the Secretariat, reviewed by
National Working Group members, and further con-
sultation was sought from stakeholders. In February
2003, the Ministry of Health, the Ministry of Public
Security and the State Food and Drug Administration
jointly issued the Temporary Scheme for Community-based
Drug Maintenance Treatment for Heroin Dependents. This
protocol laid the foundation for administrative and
technical support at all levels of government, from
national to local. The Temporary Scheme prioritized
MMT implementation in those areas most severely
affected (more than 500 drug users) and outlined eli-
gibility criteria for participation. The eligibility criteria
to participate in MMT were: (i) opiate users who had
failed more than one attempt to quit; (ii) at least two
terms in a detoxification centre or once in
a re-education-through-labour detoxification facility;
(iii) at least 20 years of age; (iv) a local resident
and settled in the local area where the clinic was
located; and (v) capable of complete civil liability.
Drug users testing HIV-positive needed only to fulfil
requirements (iv) and (v) to qualify. Clients were per-
mitted to miss a maximum of 15 days in 90 days, or
risked expulsion. They could also be expelled for
not cooperating with clinic doctors or failing to obey
program regulations, which included maintaining
abstinence from opiate use while in treatment.
The temporary scheme also outlined the safety and
security protocol to guide methadone production,
transport and distribution under the supervision of
the State Food and Drug Administration. Methadone
powder was purchased centrally and distributed to
participating provinces, which have each assigned
one pharmaceutical body to produce methadone
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Figure 2 Timeline of events in the development of China’s MMT program
SCALE UP OF CHINA’S METHADONE PROGRAM ii31liquid according to the Chinese Pharmacopoeia. In
addition, it was stipulated that the maximum daily
cost for a drug user receiving MMT services is 10
Chinese Yuan per day ( US$1.20), irrespective of
dosage. Patients had to appear in person to collect
their daily dose.
The first eight MMT pilot clinics
Between March and June 2004, the first eight MMT
clinics were established: two in Sichuan, one in
Yunnan, two in Guizhou, one in Guangxi and two
in Zhejiang. The locations of the clinics were based
on need and the local government agencies’ willing-
ness to participate. A total of 1029 clients were en-
rolled during the first calendar year of the pilot. To
estimate the effectiveness of these first eight clinics,
the national secretariat established a monitoring and
evaluation system. (This system has since become the
basis for an internet-based database that all clinics
use to enter and update information on their clients
and services.) At entry, 6 and 12 months, 585, 609
and 468 clients, respectively, were surveyed to assess
changes in drug using behaviours, drug-related crim-
inal activity, employment, family relationship and HIV
status.
20 After 6 months, the proportion of clients
who injected drugs had reduced from 69.1 to 8.9 to
8.8%, and the frequency of injection in the past
month had reduced from 90 times per month to
2 times per month. The proportion of clients reporting
employment (permanent or temporary) increased
from 22.9 to 40.6–43.2%, and self-reported
engagement in criminal activity reduced from 20.7
to 3.6–3.8%. By the third survey, 65.8% of clients
rated their relationship with their family as good,
an increase from 46.8% at entry, and 95.9% of clients
were satisfied with MMT services. Only eight HIV
sero-conversions were found among 1153 sero-
negative clients during the 12-month follow-up.
20 It
should be noted that these surveys were inher-
ently biased because they were unable to measure
outcomes among the 52% of clients who dropped
out. Despite these limitations, as early as 6 months
into the pilot, noticeable improvements among
clients provided sufficient impetus to scale-up the
program.
A major challenge during the pilot was retention.
The National Working Group tried to address this
problem by inviting various international experts to
visit the clinics and conduct an external review.
They observed that lower dosages of methadone and
the absence of adequate counselling and psychosocial
support for the clients were likely contributing to
the high drop-out rate. The Secretariat encouraged
further research on how to best improve the MMT
program.
Review and expansion of the pilot
In 2004, the first national meeting on piloting MMT
was convened among government officials from the
three key ministries, including the vice-Minister for
Health, Dr Longde Wang, and Yuanzhen Li, Deputy
Director-General of the National Narcotics Bureau,
as well as experts from related areas. The meeting
served to share the experiences, and more importantly
the problems, identified from the first phase, and to
promote rapid scale-up throughout the country under
the increasingly supportive environment. In addition,
Premier Wen Jiabao discussed the scale-up of MMT in
regions with a serious HIV/AIDS epidemic in his
speech presented before the 15th International AIDS
Conference in Bangkok in 2004, and Vice-Premier Wu
Yi did the same in her speech at the 2004 State
Council Special Assembly on HIV/AIDS Prevention
and Control.
Human resources were (and still are) one of the
major impediments to the expansion of the MMT pro-
gram. A national training centre was established in
the Yunnan Institute of Drug Abuse to provide clinical
and administrative training for key staff working in
MMT clinics. Two specific training programs are pro-
vided to trainees. The first is a 10-day intensive train-
ing course covering addiction theory, clinical practice
and administrative skills for delivery of MMT services.
To date, some 2500 staff have received this training at
the National MMT Training Centre. The second is
hands-on training provided on-site by clinical addic-
tion experts who assist local staff for the first 7 days
after a clinic has opened, to guide them in the
practice of addiction treatment and data man-
agement. Roughly, 2500 staff have received this
training.
With growing political and technical support, the
MMT program began to steadily expand. By the end of
2005, there were 58 MMT clinics opened in 11 provinces
serving 8116 drug users. Another evaluation was
conducted at 2 years to re-examine the program’s
achievements and supported earlier findings of
positive improvements among clients. Thus, the pilot
period ended and the MMT program moved to
national scale.
Legislative Support for a
Rapid Expansion
In 2006, several important policy changes occurred. The
first was promulgation of the HIV/AIDS Prevention
and Treatment Regulations, which specifically endorsed
the use of MMT as treatment for opiate addicts
(Articles 27, 63).
21 The adjoining Five-Year Action Plan
to Control HIV/AIDS (2006–10) set specific targets
for scaling up MMT; by the end of 2007 and 2010,
MMT would be made available for no fewer than 40
and 70% of opiate users, respectively, in counties/
districts with more than 500 registered drug users,
and all drug users should have at least 90% basic HIV
knowledge and condom use (Objective 6).
22
Furthermore, the Ministry of Public Security issued an
ii32 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYofficial notice to promote community-based MMT
programs, while the State Food and Drug
Administration issued regulation for the control of stu-
pefacient and mental medicine use, which is relevant to
methadone management.
Also, in July 2006, the National Working Group
revised the Temporary Scheme to improve MMT
services, and introduced The Implementation Protocol
for Community-Based Methadone Maintenance Treatment
for Opiate Addicts. Several crucial improvements were
made to benefit and cover more target groups.
Notably, the enrolment and exclusion criteria were
relaxed. For example: (i) clients are no longer
required to have a history of detoxification or several
failed attempts to quit using drugs to enter the pro-
gram; (ii) clients are no longer required to be regis-
tered as local residents and a transfer system has
been set up to meet the needs of those who are relo-
cating either permanently or temporarily; (iii) the
number of allowable missing treatment days has
been reduced to 7 consecutive days (a rare event);
and (iv) relapse is no longer a strong reason for
expulsion, though it could be considered grounds for
expulsion since the informed consent still requires cli-
ents to promise not to use illegal drugs while in treat-
ment. Furthermore, a detailed clinical guideline for
methadone treatment was added to the protocol
to support clinical practice and comprehensive inter-
ventions are highlighted in the new protocol that
suggests clinics offer ancillary services. These include
counselling, psychosocial support, testing for HIV,
syphilis, hepatitis C and tuberculosis, referrals for
antiretroviral treatment, peer education, health edu-
cation, group activities, social support and skills train-
ing for employment. The treatment fee for MMT
services was not specified, as in some areas where
heroin is easily obtained at low cost, the fee is
reduced or even waived.
With support from the above-mentioned legislation,
a decision was made by senior government officials to
accelerate the expansion. A target was set to open 300
clinics by the end of 2006. Recognizing the cost-
effectiveness of MMT relative to compulsory detoxifi-
cation, the Public Security Ministry challenged the
Secretariat to meet this target by the end of
September 2006. Under significant pressure, the
team had 305 clinics operational by this time, with
a total of 320 clinics opened by the end of that
year, serving 37345 drug users. The Ministry for
Public Security’s rationale was this: if the average
heroin user uses 0.6g/day and the average price of
heroin is CNY¥ 370 RMB/g (USD$47.44, at exchange
rate of USD$1¼CNY¥7.8 RMB in 2006), they calcu-
lated that by bringing forward the opening date
of about 200 more MMT clinics (101 clinics were al-
ready in operation by the end of July 2006) by
3 months, they could prevent the sale of 54g
(¼0.6g 90 days) of heroin per person at a value
of CNY¥ 19980 RMB (USD$2561.54, at exchange
rate of USD$1¼CNY¥7.8 RMB in 2006). Multiplied
by the number of users, the initiative would avoid
millions of dollars trade in heroin, not to mention
the millions more saved in the community by redu-
cing drug-related crimes. See supplementary data in
IJE online for details.
The expansion did not stop there. In 2007, central
government funding was also allocated to the pro-
gram, enabling those places with less than 500 regis-
tered drug users to establish MMT clinics. Another
target of 500 MMT clinics was set and 503 MMT clin-
ics were cumulatively accomplished by the end of
2007, in 23 provinces serving 97554 clients. By the
end of 2009, there were 680 clinics with some
242000 clients ever-enrolled, roughly half of whom
remain in treatment. Areas of greatest need now
have MMT clinics and the expansion has thus
slowed down.
MMT clinics have now been opened in 27 provinces.
They may be affiliated with a local Centre for Disease
Control, hospital, psychosocial health centre,
community-based health centre, voluntary detoxifica-
tion centre or a hospital in the Public Security system.
Flexibility has been enhanced by the introduction of
mobile services; the first was in Yunnan and later in
another nine provinces, with a total of 26 MMT vans.
This service enables drug users in remote, rural areas
to access to methadone. Flexibility has also been
enhanced by longer and later operating hours at
some clinics.
In June 2008, a revised Law on Drug Control was
formally issued by the People’s Congress. The law
has integrated MMT into the existing anti-drug strate-
gies requiring drug users to undergo community-
based, rather than forced, interned detoxification (up
to 2 years), and to be provided with vocational training
and employment assistance. Moreover, it requires ‘the
health sectors of provinces, autonomous regions and
municipalities to cooperate with Public Security and
the Food and Drug Administration to implement
community-based methadone maintenance treat-
ment’. This law is an important sanction for the
MMT program and will ensure its sustainability.
Monitoring and Evaluation
The role of the National Working Group
Regular monitoring and evaluation missions have been
led by senior officials from the three relevant govern-
ment sectors to improve multi-sector corporation at
local levels and investigate reasons for high drop-out
in certain clinics. During these missions, officials
convene on-site multi-sectoral meetings at different
levels, exchange opinions with local authorities, and
hear the concerns of clinical staff, addiction experts
and, most importantly, MMT clients. In 2008–9, there
were three joint monitoring and evaluation missions,
one each to Yunnan, Guangdong and Hainan, which
SCALE UP OF CHINA’S METHADONE PROGRAM ii33were used to make recommendations for improving the
program.
Every 2 years, a review meeting is organized by the
National Working Group, which includes partici-
pants from the three relevant government sectors
at national, provincial and county levels as well
as representatives from the clinics. During these meet-
ings, participants exchange and summarize their
experiences and a field trip is organized to visit
clinics that are performing well so that staff from
other clinics can observe and learn how to improve
their services.
The comprehensive web-based
management database
A national MMT program database was developed in
2004 to monitor the pilot and was later upgraded to a
web-based management database in 2008. This change
was made as part of a general move towards improving
the monitoring and evaluation of the HIV/AIDS epi-
demic in China. The database enables regular reporting
on the implementation of the program. Such informa-
tion can be used to identify gaps in the delivery of ser-
vices in a timely manner.
Each of the clinics uploads its daily services records
to the database in real time. This includes clients’
demographic information at the start of treatment,
as well as their daily dose record and the results of
any tests performed for opiate use, HIV, hepatitis C,
syphilis and tuberculosis. Behavioural risk informa-
tion is collected at entry, 6 months, 12 months
and then at 12-month intervals thereafter. These
data are also uploaded to the database, allowing the
Secretariat to measure the relative change in clients
staying in the program in order to evaluate the effect-
ives of MMT for reducing HIV risks. However, some
clinic staff fail to collect and upload patient informa-
tion, which hinders evaluation efforts. The Secretariat
is attempting to raise awareness among clinics as to
the importance of data collection for monitoring and
evaluation.
Challenges and Response
The MMT program in China is believed to have made
a considerable impact on drug use and HIV infection
among drug users in the country. In 2008 and 2009,
respectively, an estimated 2969 and 3919 new HIV
infections (excluding secondary transmission) were
prevented, consumption of heroin was reduced by
17.0 tons and 22.4 tons, and $US939 million and
US$1.24 billion in heroin trade were avoided. These
achievements can be attributed to at least three fac-
tors: strong political commitment—the MMT program
is supported legislatively and financially by the central
government multi-sector cooperation; the incorpor-
ation of MMT clinics into existing medical
infrastructure, which has facilitated delivery of ser-
vices; and the leadership role of the National
Working Group and hard work of local implementers.
However, despite the progress made, there remain a
wide range of challenges and gaps that need to be
addressed to achieve the overall goal of universal
access.
The coverage of MMT and improving
retention
A major concern is that the current coverage of
MMT may still be too low to have sufficient impact
ontheepidemic.ToreverseorstabilizetheHIVepidemic
among drug users, it has been estimated that at least
60% of drug users need to be reached with effective
interventions.
23,24 In 2009, there were 1.27 million
registered drug users in China, among whom some
600000 were injecting drug users,
25 although the
total number of drug users (including those not regis-
tered) is presumed to be much higher. Conversely, only
240000 opiate users have ever engaged in MMT, and in
December 2009 <50% of those ever enrolled were still
receiving treatment.
A problem closely related to coverage is retention,
which is less than optimal. The major reason for the
high dropout is thought to be dose.
26 The average
dose in 2009 was reported as 54mg—below
international recommendations of 60–100mg/day.
27
Low doses also contribute to relapse, which in turn
contributes to low retention rates.
26 It is possible that
clinics prefer to administer lower doses in order to
save money since clients pay CN¥10 (USD $1.28)
per dose, regardless of the volume. Alternatively,
given that most staff believe that the ultimate goal
of MMT is complete detoxification, lower doses may
seem preferable. Clinic practitioners have been
encouraged to increase the methadone doses but
many fail to do so. Clients are also reluctant to
take higher doses as they expect that the goal of
MMT should be abstinence, rather than maintenance.
This suggests that the goals of MMT are not clearly
explained to clients when they commence treatment.
Staff have also expressed their desire for further
training on how to manage patient regimens.
28 The
Implementation Protocol does not recommend any
minimum length of stay or minimal daily dose for
patients, but perhaps should give clearer guidance to
staff on how to manage dosing regimens.
Another major factor contributing to poor retention
and coverage is accessibility. In some areas, it is
simply not cost-effective to provide methadone.
Mobile clinics have helped to address this issue some-
what, but for higher coverage the program will
also need to consider more flexible dosing strategies,
such as take-home doses. Accessibility is also hin-
dered by cost. Although the daily service fee is limited
to CNY¥10 RMB (USD$ 1.28), clients may incur
additional costs, such as transport (many clinics are
ii34 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYnot centrally located, even in the cities), which
make the service too expensive for the very poor or
those who live far away (some clients live42h travel-
ling time from clinics). For some clients, the fee may
be waived or reduced to help them adhere to treat-
ment. A system to provide travel subsidies or other
reimbursements to poor clients should be considered.
A further problem contributing to drop out is inter-
ruption of treatment due to incarceration or mobility.
The program has attempted to address the mobility
problem by allowing transfers between clinics.
Interruptions to treatment due to incarceration are
more difficult to resolve as they require coordination
with law enforcements agencies in local. Many clients
may find themselves being arrested and incarcerated
due to relapse and will then be unable to continue
treatment. This puts drug users at severe risk of in-
fection with HIV, hepatitis C or other infections.
29,30
Discussions with law enforcement authorities on how
to implement MMT within such settings needs to be
addressed by creative measures.
The quality of services provided
MMT clinics can and should be employed as a com-
prehensive service platform for the control of both
HIV and drug use. Evidence exists from both
China
31,32 and abroad
33 that relapse decreases when
additional services are offered by the clinics. Ancillary
services recommended by the Secretariat include
counselling, psychosocial support, education, referrals
for related health issues and incentives. Incentives
such as reduced or waived fees are being introduced
by some clinics for clients who successfully abstain
from using other opiates while in MMT, attend
group activities or refer other drug users to the pro-
gram. These clinics have observed positive changes in
client retention. Some other clinics, however, still
focus solely on administering methadone and lack
capacity to deliver ancillary services, leaving the
service target unmet.
MMT clinics should also increase the range of ser-
vices available and improve coordination with related
services. Many drug users are at high risk of infection
by HIV, hepatitis C, sexually transmitted infections
and other blood-borne diseases.
6 The average infec-
tion rates of HIV and hepatitis C are 8.5 and 65%,
respectively, among the current MMT clients. Clients
also present with tuberculosis, sexually transmitted
infections and other infections. Currently, clients
needing treatment can only be referred for such ser-
vices at most of the clinics. In addition, many clients
continue to use drugs while in MMT and need access
to needles, but these are also unavailable at MMT
clinics. MMT clinics should offer a one-stop-shop
for comprehensive services, e.g., referral services,
counselling, social supports, needed by drug users,
rather than merely provide methadone. This would
save clients time and could improve adherence,
retention and satisfaction with the service. It would
benefit staff who would like to increase their range of
skills (see next section). The different services should
also work together to improve referrals between
services to increase the numbers of clients in MMT.
For example, designated tuberculosis clinics should
refer drug users to MMT.
Staff capacity
Although staff do receive training, their knowledge
and skills in addiction treatment and clinic manage-
ment may be inadequate.
30 Misunderstanding about
the goals of MMT (i.e. maintenance, not abstinence)
as well as confusion regarding treatment for clients
on multiple treatments, such as HIV, tuberculosis and
hepatitis C co-infection, may have adverse conse-
quences on prescribed dosage regimens and, ultim-
ately, retention. Negative attitudes of staff towards
patients can also affect retention. MMT clinic staff
do not enjoy status and may receive a lower salary
than their counterparts in other specialties.
28 There is
also little room for professional growth and many fear
their skill set becomes too narrow in MMT.
28 The
professional and monetary needs of staff need to be
addressed since staff stability has a positive impact on
MMT programs.
34 Staff management skills and their
understanding of the need to collect data for evalu-
ation also need to be improved. A series of new train-
ing curricula has recently been initiated, including
courses on ‘Psychological counseling and support among
injecting drug users’, but curricula to address other
staff weaknesses, management and data collection
should be introduced. Quality assurance monitor-
ing by the MMT Secretariat is needed to ensure
the training provided is of high quality and is
adhered to, and to ensure that staff maintain
professional, non-discriminatory attitudes towards
clients.
Multi-sector cooperation at local level
Cooperation between the Ministries of Health and
Public Security functions well at the central and
provincial levels, but less so at lower levels. Public
security and public health staff have different under-
standings of the nature of addiction, the importance
of MMT and particularly the meaning of relapse as
defined by a urine test. The fear of being registered as
a drug user deters potential clients from exposing
themselves and accessing the service; registered
drug users are sometimes harassed by police.
29
Clients may also fear arrest if police target clinics
during crackdowns as part of the War on Drugs.
The newly issued Narcotics Control Law has inte-
grated MMT as a key indicator of drug control,
which will hopefully convey the message that MMT
is a dual approach both for drug control and HIV
prevention. Training for public security officers to
help them understand the principles and operation
SCALE UP OF CHINA’S METHADONE PROGRAM ii35of MMT is being conducted but needs to reach more
officers to improve their support for the program. It
is hoped that increasing law enforcement officials’
levels of understanding about drug use will make
them more amenable to the inclusion of MMT in
closed settings.
Conclusion
China has made impressive progress in moving its
MMT program from a pilot project to a national
scale. Experiences and lessons learned from this
period will be applied to continued improvement of
the program. Many important challenges remain
before the program will achieve its desired success.
Key goals to improve the program include: (i) increas-
ing the coverage of MMT and the number of its ben-
eficiaries; (ii) improving accessibility of services; (iii)
improving the quality of services offered, increasing
the range of services offered at clinics and introducing
referral systems between related services; (iv) provid-
ing on-going staff training to improve the quality of
their service, increase their understanding of drug
addiction and enhance their professionalism; and
(v) enhancing multi-sector cooperation, especially at
local levels to ensure that clients enjoy uninterrupted
treatment. These improvements will enable the pro-
gram to reach the ambitious targets set by the
Government and improve the life of the drug users
to reverse both the HIV/AIDS and drug abuse
epidemics.
Supplementary Data
Supplementary data are available at IJE online for
calculating benefits from bringing forward the open-
ing date of about 200 more MMT clinics in 2006.
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KEY MESSAGES
  China has rapidly expanded methadone maintenance programs in response to HIV/AIDS epidemic
among drug use population in past years;
  Methadone treatment services have been extended to offer clients a range of ancillary services,
including HIV, syphilis and hepatitis C testing, information, education and communication, psycho-
social support services and referrals for treatment of HIV, tuberculosis and sexually transmitted
diseases;
  Institutional capacity building at methadone clinics is still needed to deliver sustainable and stan-
dardized services that will ultimately improve methadone treatment program.
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